CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Marta Luna-Sánchez
  • Agustín Hidalgo-Gutiérrez
  • Tatjana M. Hildebrandt
  • Julio Chaves-Serrano
  • Eliana Barriocanal-Casado
  • Ángela Santos-Fandila
  • Miguel Romero
  • Ramy K.A. Sayed
  • Juan Duarte
  • Holger Prokisch
  • Markus Schuelke
  • Felix Distelmaier
  • Germaine Escames
  • Darío Acuña-Castroviejo
  • Luis C. López

Research Organisations

External Research Organisations

  • University of Granada
  • Abbott Laboratories (Granada)
  • Sohag University
  • Technical University of Munich (TUM)
  • Charité - Universitätsmedizin Berlin
  • University Hospital Düsseldorf
View graph of relations

Details

Original languageEnglish
Pages (from-to)78-95
Number of pages18
JournalEMBO molecular medicine
Volume9
Issue number1
Publication statusPublished - 1 Jan 2017

Abstract

Coenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in the cellular metabolism. One of them is to function as an electron carrier in the reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes the first reaction in the hydrogen sulfide oxidation pathway. Therefore, SQR may be affected by CoQ deficiency. Using human skin fibroblasts and two mouse models with primary CoQ deficiency, we demonstrate that severe CoQ deficiency causes a reduction in SQR levels and activity, which leads to an alteration of mitochondrial sulfide metabolism. In cerebrum of Coq9R239X mice, the deficit in SQR induces an increase in thiosulfate sulfurtransferase and sulfite oxidase, as well as modifications in the levels of thiols. As a result, biosynthetic pathways of glutamate, serotonin, and catecholamines were altered in the cerebrum, and the blood pressure was reduced. Therefore, this study reveals the reduction in SQR activity as one of the pathomechanisms associated with CoQ deficiency syndrome.

Keywords

    blood pressure, COX, glutathione, mitochondrial disease, SQR

ASJC Scopus subject areas

Cite this

CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. / Luna-Sánchez, Marta; Hidalgo-Gutiérrez, Agustín; Hildebrandt, Tatjana M. et al.
In: EMBO molecular medicine, Vol. 9, No. 1, 01.01.2017, p. 78-95.

Research output: Contribution to journalArticleResearchpeer review

Luna-Sánchez, M, Hidalgo-Gutiérrez, A, Hildebrandt, TM, Chaves-Serrano, J, Barriocanal-Casado, E, Santos-Fandila, Á, Romero, M, Sayed, RKA, Duarte, J, Prokisch, H, Schuelke, M, Distelmaier, F, Escames, G, Acuña-Castroviejo, D & López, LC 2017, 'CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome', EMBO molecular medicine, vol. 9, no. 1, pp. 78-95. https://doi.org/10.15252/emmm.201606345
Luna-Sánchez, M., Hidalgo-Gutiérrez, A., Hildebrandt, T. M., Chaves-Serrano, J., Barriocanal-Casado, E., Santos-Fandila, Á., Romero, M., Sayed, R. K. A., Duarte, J., Prokisch, H., Schuelke, M., Distelmaier, F., Escames, G., Acuña-Castroviejo, D., & López, L. C. (2017). CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. EMBO molecular medicine, 9(1), 78-95. https://doi.org/10.15252/emmm.201606345
Luna-Sánchez M, Hidalgo-Gutiérrez A, Hildebrandt TM, Chaves-Serrano J, Barriocanal-Casado E, Santos-Fandila Á et al. CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. EMBO molecular medicine. 2017 Jan 1;9(1):78-95. doi: 10.15252/emmm.201606345
Luna-Sánchez, Marta ; Hidalgo-Gutiérrez, Agustín ; Hildebrandt, Tatjana M. et al. / CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. In: EMBO molecular medicine. 2017 ; Vol. 9, No. 1. pp. 78-95.
Download
@article{57402c79903e4072843cffad834f998e,
title = "CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome",
abstract = "Coenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in the cellular metabolism. One of them is to function as an electron carrier in the reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes the first reaction in the hydrogen sulfide oxidation pathway. Therefore, SQR may be affected by CoQ deficiency. Using human skin fibroblasts and two mouse models with primary CoQ deficiency, we demonstrate that severe CoQ deficiency causes a reduction in SQR levels and activity, which leads to an alteration of mitochondrial sulfide metabolism. In cerebrum of Coq9R239X mice, the deficit in SQR induces an increase in thiosulfate sulfurtransferase and sulfite oxidase, as well as modifications in the levels of thiols. As a result, biosynthetic pathways of glutamate, serotonin, and catecholamines were altered in the cerebrum, and the blood pressure was reduced. Therefore, this study reveals the reduction in SQR activity as one of the pathomechanisms associated with CoQ deficiency syndrome.",
keywords = "blood pressure, COX, glutathione, mitochondrial disease, SQR",
author = "Marta Luna-S{\'a}nchez and Agust{\'i}n Hidalgo-Guti{\'e}rrez and Hildebrandt, {Tatjana M.} and Julio Chaves-Serrano and Eliana Barriocanal-Casado and {\'A}ngela Santos-Fandila and Miguel Romero and Sayed, {Ramy K.A.} and Juan Duarte and Holger Prokisch and Markus Schuelke and Felix Distelmaier and Germaine Escames and Dar{\'i}o Acu{\~n}a-Castroviejo and L{\'o}pez, {Luis C.}",
note = "Funding information: We are grateful to Dr. Iryna Rusanova (Universidad de Granada) for her technical support. We thank to Pol Herrero (Metabolomics Facility at the Center for Omic Sciences (COS) of the University Rovira i Virgili, recognized as a Singular Research and Technology Infrastructure by the Spanish Ministry of Economy and Competitiveness) for his contributions to mass spectrometry analysis. This work was supported by grants from Ministerio de Econom{\'i}a y Competitividad, Spain, and the ERDF (SAF2013-47761-R, SAF2014-55523-R, RD12/0042/0011 and SAF2015-65786-R), from the Consejer{\'i}a de Econom{\'i}a, Innovaci{\'o}n, Ciencia y Empleo, Junta de Andaluc{\'i}a (P10-CTS-6133), from the NIH (P01HD080642) and from the foundation “todos somos raros, todos somos {\'u}nicos”. MLS is a predoctoral fellow from the Consejer{\'i}a de Econom{\'i}a, Innovaci{\'o}n, Ciencia y Empleo, Junta de Andaluc{\'i}a. LCL is supported by the “Ram{\'o}n y Cajal” National Programme, Ministerio de Econom{\'i}a y Competitividad, Spain (RYC-2011-07643).",
year = "2017",
month = jan,
day = "1",
doi = "10.15252/emmm.201606345",
language = "English",
volume = "9",
pages = "78--95",
journal = "EMBO molecular medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "1",

}

Download

TY - JOUR

T1 - CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome

AU - Luna-Sánchez, Marta

AU - Hidalgo-Gutiérrez, Agustín

AU - Hildebrandt, Tatjana M.

AU - Chaves-Serrano, Julio

AU - Barriocanal-Casado, Eliana

AU - Santos-Fandila, Ángela

AU - Romero, Miguel

AU - Sayed, Ramy K.A.

AU - Duarte, Juan

AU - Prokisch, Holger

AU - Schuelke, Markus

AU - Distelmaier, Felix

AU - Escames, Germaine

AU - Acuña-Castroviejo, Darío

AU - López, Luis C.

N1 - Funding information: We are grateful to Dr. Iryna Rusanova (Universidad de Granada) for her technical support. We thank to Pol Herrero (Metabolomics Facility at the Center for Omic Sciences (COS) of the University Rovira i Virgili, recognized as a Singular Research and Technology Infrastructure by the Spanish Ministry of Economy and Competitiveness) for his contributions to mass spectrometry analysis. This work was supported by grants from Ministerio de Economía y Competitividad, Spain, and the ERDF (SAF2013-47761-R, SAF2014-55523-R, RD12/0042/0011 and SAF2015-65786-R), from the Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (P10-CTS-6133), from the NIH (P01HD080642) and from the foundation “todos somos raros, todos somos únicos”. MLS is a predoctoral fellow from the Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía. LCL is supported by the “Ramón y Cajal” National Programme, Ministerio de Economía y Competitividad, Spain (RYC-2011-07643).

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Coenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in the cellular metabolism. One of them is to function as an electron carrier in the reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes the first reaction in the hydrogen sulfide oxidation pathway. Therefore, SQR may be affected by CoQ deficiency. Using human skin fibroblasts and two mouse models with primary CoQ deficiency, we demonstrate that severe CoQ deficiency causes a reduction in SQR levels and activity, which leads to an alteration of mitochondrial sulfide metabolism. In cerebrum of Coq9R239X mice, the deficit in SQR induces an increase in thiosulfate sulfurtransferase and sulfite oxidase, as well as modifications in the levels of thiols. As a result, biosynthetic pathways of glutamate, serotonin, and catecholamines were altered in the cerebrum, and the blood pressure was reduced. Therefore, this study reveals the reduction in SQR activity as one of the pathomechanisms associated with CoQ deficiency syndrome.

AB - Coenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in the cellular metabolism. One of them is to function as an electron carrier in the reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes the first reaction in the hydrogen sulfide oxidation pathway. Therefore, SQR may be affected by CoQ deficiency. Using human skin fibroblasts and two mouse models with primary CoQ deficiency, we demonstrate that severe CoQ deficiency causes a reduction in SQR levels and activity, which leads to an alteration of mitochondrial sulfide metabolism. In cerebrum of Coq9R239X mice, the deficit in SQR induces an increase in thiosulfate sulfurtransferase and sulfite oxidase, as well as modifications in the levels of thiols. As a result, biosynthetic pathways of glutamate, serotonin, and catecholamines were altered in the cerebrum, and the blood pressure was reduced. Therefore, this study reveals the reduction in SQR activity as one of the pathomechanisms associated with CoQ deficiency syndrome.

KW - blood pressure

KW - COX

KW - glutathione

KW - mitochondrial disease

KW - SQR

UR - http://www.scopus.com/inward/record.url?scp=85003702491&partnerID=8YFLogxK

U2 - 10.15252/emmm.201606345

DO - 10.15252/emmm.201606345

M3 - Article

C2 - 27856619

AN - SCOPUS:85003702491

VL - 9

SP - 78

EP - 95

JO - EMBO molecular medicine

JF - EMBO molecular medicine

SN - 1757-4676

IS - 1

ER -